Dermatitis

DERMATITIS

FEATURE ARTICLE

Addressing Skin Pain in Atopic Dermatitis

Tori Rodriguez, MA, LPC, AHC

The burden of pain as a component of atopic dermatitis treatment should be assessed and managed in a thorough manner.

LATEST NEWS

EASI 50, SCORAD 35, and O-SCORAD 35 May Be Most Meaningful MICs for Atopic Dermatitis

Colby Stong

The minimal important changes of percentage and absolute improvement of EASI and SCORAD scores in adults and children with AD was determined.

Topical Live Biotherapeutic Gets Fast Track Status for Atopic Dermatitis

Brian Park, PharmD

FB-401 is a topically applied live biotherapeutic that consists of 3 therapeutic strains of commensal Roseomonas mucosa.

AbbVie Seeks Approval of Upadacitinib for Atopic Dermatitis

Brian Park, PharmD

The regulatory application is supported by data from 3 randomized, double-blind, placebo-controlled phase 3 studies.

eczema or atopic dermatitis on foot of a baby or infant

Topical Antibiotics Plus TCS Do Not Increase Clinical Benefit in Infant AD

Brandon May

The goal of this study was to determine whether adding topical antibiotics to topical corticosteroids led to additional clinical improvement in infants with moderate to severe atopic dermatitis during a short-term follow-up period.

Black woman looking at her scalp, skin of color

Allergic Contact Dermatitis Most Frequent in Patients With Affected Areas Adjacent to the Scalp

Brandon May

Patients with scalp involvement and their patch testing outcomes were characterized in this study analyzing allergic contact dermatitis.

Topical Calcineurin Inhibitors, Keratinocyte Carcinoma, and Risk in Atopic Dermatitis

Colby Stong

Investigators sought to assess the overall keratinocyte carcinoma risk and by subtype in adults with atopic dermatitis exposed to topical calcineurin inhibitors.

Dupilumab Use for Atopic Dermatitis Remains High at 1 Year

Colby Stong

A study sought to characterize adults with atopic dermatitis who initiated dupilumab and evaluate persistence on therapy.

Dupilumab vs Cyclosporin for Treatment of Atopic Dermatitis

Colby Stong

Drug survival of dupilumab compared with cyclosporin, the reasons for drug discontinuation, and the predictive parameters of drug survival were analyzed.